Reaction

5Q Minus Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 159 reports · 2 co-occurring drugs

As of the last recalculation, 5Q Minus Syndrome appears in 159 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 84.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fludarabine Phosphate2284.884.9
Lenalidomide8048.948.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.